It is known that gaining the Pcsk9 function mutations is coupled with cardiovascular diseases and autosomal dominant hypercholesterolemia, while their loss lead to decreased LDL-C levels in plasma, consequently mitigating the risks of cardiovascular diseases [61]. Here, PCSK9 is linked to cardiovascular disorder.